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Abstract
This study was performed to determine a sampling strategy to quantify the prevalence of antimicrobial resistance on veal
calf farms, based on the variation in antimicrobial resistance within and between calves on five farms. Faecal samples from
50 healthy calves (10 calves/farm) were collected. From each individual sample and one pooled faecal sample per farm, 90
selected Escherichia coli isolates were tested for their resistance against 25 mg/L amoxicillin, 25 mg/L tetracycline, 0.5 mg/L
cefotaxime, 0.125 mg/L ciprofloxacin and 8/152 mg/L trimethoprim/sulfamethoxazole (tmp/s) by replica plating. From each
faecal sample another 10 selected E. coli isolates were tested for their resistance by broth microdilution as a reference.
Logistic regression analysis was performed to compare the odds of testing an isolate resistant between both test methods
(replica plating vs. broth microdilution) and to evaluate the effect of pooling faecal samples. Bootstrap analysis was used to
investigate the precision of the estimated prevalence of resistance to each antimicrobial obtained by several simulated
sampling strategies. Replica plating showed similar odds of E. coli isolates tested resistant compared to broth microdilution,
except for ciprofloxacin (OR 0.29, p#0.05). Pooled samples showed in general lower odds of an isolate being resistant
compared to individual samples, although these differences were not significant. Bootstrap analysis showed that within
each antimicrobial the various compositions of a pooled sample provided consistent estimates for the mean proportion of
resistant isolates. Sampling strategies should be based on the variation in resistance among isolates within faecal samples
and between faecal samples, which may vary by antimicrobial. In our study, the optimal sampling strategy from the
perspective of precision of the estimated levels of resistance and practicality consists of a pooled faecal sample from 20
individual animals, of which 90 isolates are tested for their susceptibility by replica plating.
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Introduction
Antimicrobial resistance is an increasing problem and a global
threat for human and animal health. Antimicrobial usage is
considered a major determinant for emergence, selection and
dissemination of antimicrobial resistant microorganisms [1], [2],
[3]. Moreover, there is increasing evidence that transmission of
antimicrobial drug resistant commensal and zoonotic bacteria, like
methicillin resistant Staphylococcus aureus (MRSA) and extended
spectrum beta-lactamase producing Escherichia coli, from food
producing animals to humans may occur [4], [5], [6], [7], [8]. In
response to public and animal health concerns, antimicrobial
resistance monitoring programmes have been developed and
implemented on national [9] and European level [10]. These
programmes monitor and report antimicrobial drug resistance
among commensal and zoonotic bacteria from food producing
animals, like veal calves. These monitoring programmes, however,
provide no information on the prevalence of antimicrobial
resistance on farm-level while this information is vital to identify
risk factors for the development and spread of antimicrobial
resistance within farms.
Studies to determine the prevalence of antimicrobial resistance
on farms are generally based upon measuring resistance of
commensal bacteria from the intestines of farm animals, like
Enterococcus spp. and E. coli. These bacteria are considered good
indicator organisms to monitor the effects of the selective pressure
exerted by the use of antimicrobials in food animals [11].
Moreover, E. coli and enterococci constitute a natural part of the
intestinal flora of animals, which facilitates the comparison of
resistance percentages between populations [12], [13].
Bacterial isolates can be tested for their resistance in several
ways, for example using broth microdilution or replica plating.
With broth microdilution an isolate is tested against a panel of
antimicrobials. This method is used worldwide in monitoring
programmes and can be considered to be the ‘gold standard’ [13].
Replica plating on the other hand is a more feasible and cost-
effective method to quantify resistance within animal populations
since multiple isolates can be tested simultaneously for their
resistance using agar plates containing an antimicrobial at a
breakpoint concentration [14], [15].
In order to determine resistance on herd-level a multi-level
approach is needed [16]. One needs to know how many animals
within the herd have to be sampled, and how many isolates per
faecal sample have to be tested to get a representative resistance
level. For this purpose the variation in resistance among isolates
within a faecal sample and the variation among faecal samples
within a herd have to be investigated and taken into account.
Although several studies on prevalence of antimicrobial
resistance within herds have been performed, only a few studies
addressed the variation in resistance of isolates within and among
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faecal samples and used this information to investigate the effect of
different sampling strategies on the precision of estimated
resistance levels. In a study among dairy cows the variance in
resistance to 12 antimicrobials was mainly attributable to variation
among isolates. Based on this information four different sampling
strategies were simulated and it was suggested that testing 3–4
isolates per cow (from 33 resp. 25 cows) was the best strategy to
determine the prevalence of antimicrobial resistance at herd-level
[17]. Among finisher pigs the largest component of variance in
resistance to tetracycline and gentamicin existed between pigs
within the same pen (97.5%). Bootstrap analysis based on these
data revealed that for tetracycline at least 5 isolates per faecal
sample need to be tested, whereas for gentamicin testing more
than 10 isolates per faecal sample would result in precise estimates
of resistance at herd-level [18]. Among broiler chickens the
variation of resistance among isolates was low meaning that focus
should be on the number of animals sampled within a flock rather
than on the number of isolates tested within one animal [19].
These studies show that the composition of the variance influences
the choice for a sampling strategy in order to measure
antimicrobial resistance at herd-level. Due to species-specific
factors that might play a role in the development and spread of
antimicrobial resistant isolates within a herd (e.g. age, housing and
management related factors) conclusions from these studies may
not be representative for the situation within veal calf herds.
The aim of this study was to determine a sampling strategy
based on the variation in proportions of resistant isolates within
and among faecal samples from veal calves in order to estimate the
prevalence of resistance on herd-level. For this purpose we
quantified and compared the proportions of resistant commensal
E. coli isolated from veal calves, using two different test methods
(replica plating versus broth microdilution) and two different
sample types (individual samples versus pooled samples).
Materials and Methods
Ethics Statement
The veal calf farms in this study belonged to a veal calf
integration and were visited in accompany of a veterinary staff
member of that integration. On the farms, selected veal calves
were restrained individually and only during the time needed to
obtain faecal samples. Rectal samples were taken manually using
disposable gloves and a lubricant. Before this study started an
animal welfare officer of the faculty of veterinary medicine,
Utrecht University, was contacted and information on required
permits or approvals for this study was inquired. It seemed that
this study fell into the scope of the policy of the faculty on client-
related animal research as the study was performed under the
authority of the integration (the owner of the veal calves) and
therefore no approval was required.
Collection of Faecal Samples
Five veal calf farms were selected out of the farm database of a
veal producing company based on their stage in the fattening
period (e.g. end of fattening period/close to slaughter). The five
selected farms cover the range in farm sizes and were considered
representative for the veal calf fattening sector in The Netherlands.
Some farm characteristics of the five selected farms, i.e. farm size,
number of barns on the farms and administered oral group
medication, are presented in Table 1.
All calves received at the start of the fattening period an oral
group treatment of oxytetracycline-HCl in combination with
colistin. On 4 of the 5 farms an additional oral group treatment of
ampicillin, doxycycline or tylosin was administered to the calves
during the fattening period.
The five selected farms were all visited on the same day to
collect faecal samples. On each farm, the barn closest to the
entrance was selected for sampling. Within this barn five pens and
two calves per pen were selected at convenience. The five pens
were equally distributed over the barn and each pen housed 5–10
veal calves. The ten selected calves did not show any signs of
diarrhoea or coughing and where not under antimicrobial
treatment at the moment of sampling. Faecal samples were
collected manually per rectum and suspended 1:10 (w/v) in
buffered peptone broth containing 30% glycerol within 24 hours.
Moreover for each farm a pooled sample was made by mixing
1 ml of every individual faecal suspension. All samples were stored
at 220uC until further processing.
Susceptibility Testing and Microbiological Analysis of
Faecal Samples
The stored individual and pooled faecal samples were thawed
and tenfold dilution series were made in saline. From each dilution
two MacConkey No.3 (MAC) agar plates (bioTRADING Benelux
B.V., Mijdrecht, The Netherlands) were inoculated, each with
50 ml suspension, and incubated overnight at 37uC. From the
dilution which provided up to 300 solitary colonies, one MAC
agar plate was used for replica plating, and the other MAC agar
plate was used for the broth microdilution test method.
Replica Plating
Per individual or pooled sample 90 colonies with the
morphological appearance of E. coli were selected from the
MAC agar plate. The colonies were picked from the agar using
sterilized toothpicks and each colony was suspended in an
individual well of a 96-wells microtitre plate, resulting in 90
isolates. Each well contained 100 ml cation-adjusted Mueller
Hinton broth (CAMHB) (Trek Diagnostic Systems, Basingstoke,
UK) and isolates were suspended to an optical density of
approximately 1–2 McFarland. Also reference strains E. coli
ATCC 25922, E. faecalis ATCC 29212, S. aureus ATCC 29213,
and Pseudomonas aeruginosa ATCC 27853 and two negative controls
were included in each 96-wells plate to verify the antimicrobial
concentration in the agar plates and reproducibility. Mueller
Hinton (MH) agar plates with and without an antimicrobial
breakpoint concentration were prepared and manually poured
into rectangular Petri dishes (40 ml) (VWR International B.V.,
Amsterdam, The Netherlands). The MH agar plates contained the
following antimicrobials and their breakpoint concentrations:
25 mg/L amoxicillin, 25 mg/L tetracycline, 0.5 mg/L cefotax-
ime, 0.125 mg/L ciprofloxacin and 8/152 mg/L tmp/s [12],
Table 1. Farm characteristics of the five selected veal calf
farms.
# Calves # Barns Oral group medication
Farm 1 416 3 Oxytetracycline-HCl, Colistin, Doxycycline
Farm 2 1030 2 Oxytetracycline-HCl, Colistin, Ampicillin
Farm 3 1335 2 Oxytetracycline-HCl, Colistin, Tylosin
Farm 4 190 1 Oxytetracycline-HCl, Colistin, Ampicillin
Farm 5 898 3 Oxytetracycline-HCl, Colistin
Distribution of farm sizes in The Netherlands (n = 2064): 53% ,450 veal calves/
farm, 22% 450–750 veal calves/farm, 25% .750 veal calves/farm.
doi:10.1371/journal.pone.0044831.t001
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[20], [21], [22]. These antimicrobials were chosen as representa-
tives of classes of antimicrobials regularly used in veal calf
production. The used breakpoint concentrations for each antimi-
crobial differed one or two-steps up in dilution from the EUCAST
epidemiological cut-off values to prevent an overestimation of the
prevalence of resistance due to an inoculum effect [23]. The
concentrations in the MH agar plates were validated by
inoculating isolates with known MIC values from the strain
collection of CVI Lelystad. A sterile 96-pin replicator (Genetix
Ltd., Hampshire, UK) was used to transfer the suspended isolates
from the 96-wells plate onto a series of MH agar plates in the
following order: MH containing resp. amoxicillin, tetracycline,
cefotaxime, ciprofloxacin and tmp/s. MH agar plates without an
antimicrobial agent were included at the beginning and end of
each replicating series to control for growth [24]. Replicating was
performed using one replicator per replicating series. Incubation of
inoculated MH agar plates was done at 37uC for 18–20 hours.
The isolates that grew on the MH agar plates containing an
antimicrobial were considered to be resistant.
For two individual faecal samples (from farm 4 and 5)
insufficient growth of E. coli was observed on the MAC agar
plates to test the isolates by replica plating (,90 colonies).
Therefore these samples were excluded from the replica plating
dataset.
In total 4320 isolates from 48 individual samples and 450
isolates from 5 pooled samples were tested for their resistance
against the five antimicrobials by replica plating.
Broth Microdilution
From the second MAC agar plate ten colonies with the
morphological appearance of E. coli were selected per individual
and pooled sample and confirmed as E. coli by a positive indole
test. For these ten E. coli isolates per sample Minimum Inhibitory
Concentrations (MIC) were determined by broth microdilution
according to ISO standard 20776-1-2006. Briefly, from fresh
overnight cultures on blood agar, inocula were prepared in saline
with a turbidity of 0.5 McFarland. Final inocula were prepared by
200-fold dilution of these suspensions in CAMHB. Microtitre trays
(EUMVS type, Trek Diagnostic Systems, Basingstoke, UK) with
dehydrated dilution ranges of panels of antibiotics were used to
monitor resistance to ampicillin, tetracycline, cefotaxime, cipro-
floxacin and tmp/s. Each well of the microtitre tray was inoculated
with 50 ml of the final inoculum. ATCC strains E. coli 25922 and
E. faecalis 29212 were included to monitor the quality of the results.
After inoculation of the wells the microtitre trays were sealed and
incubated at 35uC for 18 to 24 hours. EUCAST epidemiological
cut-off values (ampicillin #8 mg/L, tetracycline #8 mg/L,
cefotaxime #0.25 mg/L, ciprofloxacin #0.03 mg/L, trimetho-
prim #2 mg/L, and sulphamethoxazole #64 mg/L) were used to
differentiate between wild-type isolates and isolates with reduced
susceptibility [25]. Isolates with non-wild type susceptibility to both
trimethoprim and sulphamethoxazole were considered resistant to
tmp/s.
In total 500 isolates from 50 individual samples and 50 isolates
from 5 pooled samples were tested for their resistance using broth
microdilution.
Statistical Analysis
Logistic regression analysis. A generalised linear mixed
model with a logit link function was used to study the relationship
between the binomial distribution of the grouped outcome
(number of resistant isolates on the total number of isolates tested
per faecal sample) and explanatory variables antimicrobial, test
method and sample type, including the 2-way interaction between
antimicrobial and test method or sample type and the 3-way
interaction between antimicrobial, test method and sample type. A
random farm, a random pen and a random faecal sample effect
were included in the model to take into account the clustering of
faecal samples within farms and pens, and the clustering of isolates
within a faecal sample.
The random effects were assumed to have a compound
symmetry covariance structure. A backward stepwise selection
on the full model was performed to find the best fitting model to
describe the dataset. Selection of the best fitting model was based
on the value of Akaike’s Information Criteria (AIC). The model
with the lowest AIC value was considered the best fitting model,
with the AIC being the 22*loglikelihood +2*the number of
parameters in the model. The odds ratio and 95% confidence
interval for the explanatory variables in the best fitting model were
calculated.
The estimated variance values of the random effects in the best
fitting model were used to examine the variation (proportion from
total) in antimicrobial resistance on farm-level, pen-level and
sample-level, with the variance of a standard logistic density fixed
at ð2/3 [26]. The analyses were performed using open-source
programme R, version 2.12.2 [27] and package lme4, version
0.999375-42 [28] for generalized linear mixed-effects models using
the Laplace approximation method.
Bootstrap analysis. Bootstrap analysis was performed to test
possible sampling strategies for their effect on estimated propor-
tions of resistance within a sample, based on the distribution of
data in the observed dataset [29]. The analysis was based on the
dataset containing the resistance results of 4320 isolates collected
from the individual veal calf samples and tested by replica plating.
This dataset was used because replica plating is our preferred test
method based on precision, feasibility and cost effectiveness. Also
the dataset contained more data and obtained similar results
compared to the broth microdilution dataset (Table 2).
Eight sampling strategies, each representing a different compo-
sition of a pooled sample, were simulated. These strategies were
based on the variability of resistance within and between samples
and included various compositions of pooled samples varying the
number of isolates and number of samples to investigate the
precision of the sampling strategies on the estimated prevalence of
resistance. The simulation of a pooled sample was justified,
because logistic regression analysis showed that the odds of an
isolate being resistant did not significantly differ between
individual and pooled samples (Table 2).
The sampling strategies, in part based on Dunlop et al. [18],
lead to total sample sizes of 20, 40 and 100 isolates tested per farm,
representing a small, medium or large sample size from a practical
point of view. The various compositions of a pooled sample were
implemented to determine if focus should be on the number of
faecal samples included or on the number of isolates tested per
sample in order to get precise farm resistance levels.
Per sampling strategy and for each antimicrobial, a set of 1000
bootstrap samples was drawn from the dataset (individual samples
tested with replica plating) with replacement, where each
observation had an equal probability of selection. Within each
bootstrap sample the sampling strategy was simulated per farm by
selecting, with replacement, first the number of faecal samples
(varying from 4–20 faecal samples depending on the sampling
strategy) and secondly within these faecal samples the number of
isolates (varying from 2–20 isolates per sample depending on the
sampling strategy). Each bootstrap sample comprised the data of
the simulated sampling strategy from all five farms combined.
Logistic regression analysis for grouped data (pooled sample per
farm) and logit link was performed on each bootstrap sample, and
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the estimated coefficient for the intercept was used to calculate the
proportion isolates resistant to each antimicrobial (proportion
resistant isolates = e intercept/(1+ e intercept)). Based on the distribu-
tion of these estimated proportions from 1000 bootstrap samples
per sampling strategy, values for the mean, standard deviation and
the 2.5th and 97.5th percentile were calculated. Bootstrap analysis
was performed using open-source programme R, version 2.12.2
[27].
Results
Descriptive Statistics
The number and proportion of isolates tested resistant for each
antimicrobial by replica plating and broth microdilution using
individual and pooled samples are presented in Table 3. The MIC
distribution of isolates tested with broth microdilution is presented
in Table 4. The proportion of resistant isolates tested among
individual samples by replica plating was high for tetracycline
(0.92), intermediate for amoxicillin and tmp/s (0.61 and 0.47,
respectively) and low for ciprofloxacin and cefotaxime (0.11 and
0.02, respectively). Due to the lack of resistant isolates for
cefotaxime in broth microdilution the results for cefotaxime were
left out the statistical model.
Logistic Regression Analysis
Based on the AIC, the best fitting model included explanatory
variables antimicrobial, test method and sample type and the 2-
way interaction term between antimicrobial and test method and
between antimicrobial and sample type. The 3-way interaction
term between antimicrobial, test method and sample type was left
out of the model because it was not significant.
The best fitting model showed no significant difference in the
odds of resistant isolates using replica plating compared to broth
microdilution for the antimicrobials amoxicillin (OR 1.23,
p=0.07), tetracycline (OR 1.26, p=0.19) and tmp/s (OR 1.12,
p=0.31) (Table 2). For ciprofloxacin, on the other hand, a
significant lower odds of resistant isolates was found by replica
plating (OR 0.29, p=,2e-16 ). Pooled samples showed lower odds
of resistant isolates for the antimicrobials amoxicillin, ciprofloxacin
and tmp/s (OR,1) and a higher odds of resistant isolates for
tetracycline (OR=1.21) compared to individual samples, although
these differences were not significant (p.0.05).
Based on the estimated variance values of the random effects in
the best fitting model, the largest proportion of total variance was
found between faecal samples, followed by variance between farms
and pens (0.25, 0.22 and 0.01 resp.).
Bootstrap Analysis
The effect of sampling strategy on the distribution of the
estimated proportion of E. coli isolates resistant to the five tested
antimicrobials is presented in Table 5. The various sampling plans
yielded consistent values for the estimated mean proportion of
isolates resistant to amoxicillin (0.61) tetracycline (0.92), ciproflox-
acin (0.11) and tmp/s (0.46–0.47).
Precision of the estimated mean proportions of each sampling
strategy was determined by the width of the interval between the
2.5th and 97.5th percentile. The 2.5th and 97.5th percentile interval
became more narrow when increasing the total number of isolates
tested. Also within a fixed total number of isolates tested increasing
the number of samples and consequently decreasing the number of
isolates tested per sample resulted in a narrower precision interval.
All bootstrap results were estimable and no extreme prevalence
values were estimated.
Discussion
In search for a sampling strategy to estimate resistance levels
within a veal calf herd we investigated the reliability of the replica
plating test method by comparing the obtained results to broth
microdilution as a reference. With replica plating isolates were
tested for their resistance using breakpoint concentrations one or
two twofold dilution steps higher compared to EUCAST
epidemiological cut-off values. Nevertheless, this method has
proven to provide results comparable to those obtained with broth
microdilution for amoxicillin, tetracycline and tmp/s. For
ciprofloxacin a significantly lower odds of resistant isolates by
replica plating was found. Two other studies also compared the
prevalence of resistant isolates per sample using antimicrobial
Table 2. Logistic regression analysis of explanatory variables test method and sample type including their interaction with the
tested antimicrobials on the odds of resistant isolates in faecal samples.
Variable b SE(b) p OR 95% CI
Lower Upper
Test method Broth microdilution Reference 1
Replica plating - Amox 0.20 0.11 0.07 1.23 0.98 1.53
Replica plating - Cip 21.23 0.14 ,2e-16 0.29 0.22 0.38
Replica plating - Tet 0.23 0.18 0.19 1.26 0.89 1.79
Replica plating - Tmp/s 0.12 0.11 0.31 1.12 0.90 1.40
Sample type Individual sample Reference 1
Pooled sample - Amox 20.56 0.62 0.36 0.57 0.17 1.91
Pooled sample - Cip 20.65 0.64 0.31 0.52 0.15 1.84
Pooled sample - Tet 0.19 0.64 0.77 1.21 0.34 4.27
Pooled sample - Tmp/s 20.26 0.62 0.68 0.77 0.23 2.59
Amox= amoxicilline, Cip = ciprofloxacine, Tet = tetracycline, Tmp/s = trimethoprim/sulfa-methoxazole.
Variance random sample effect = 1.561.
Variance random pen effect = 0.084.
Variance random farm effect = 1.413.
doi:10.1371/journal.pone.0044831.t002
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containing agar plates versus a dilution test method as reference
using different breakpoints. Vieira et al. [15] compared the
prevalence of tetracycline and sulphonamide resistance between
both methods using similar breakpoint concentrations for tetracy-
cline, whereas the agar plates contained a breakpoint concentra-
tion one dilution step up for sulphonamide. O¨sterblad et al. [24]
compared the prevalence of resistance to ampicillin, trimethoprim
and tetracycline using breakpoint concentrations one step dilution
up for ampicillin, and one step dilution down for trimethoprim
and tetracycline compared to the reference method. Despite the
use of different breakpoint concentrations compared to the
reference method, the rate of resistance detection did not differ
statistically between the test methods for any of the antibiotics
tested. These results can be explained by the bimodal distribution
of MIC values of E. coli isolates around the used breakpoint
concentrations for ampicillin, tetracycline, cefotaxime and tri-
methoprim and sulphamethoxazole (Table 4). For this reason the
use of a higher breakpoint concentration of these antimicrobials in
an agar plate did not give different resistance results compared to
broth microdilution using EUCAST epidemiological cut-off
values. For ciprofloxacin, on the other hand, MIC values of the
isolates were distributed around the breakpoint concentrations
used within both test methods due to the fact that development of
resistance to ciprofloxacin increases gradually by single-step
mutations in the chromosome [30]. Thus, a one or two-step
higher dilution in breakpoint concentration resulted in a lower
prevalence of resistance to ciprofloxacin found by replica plating.
Besides test method, also the application of pooled samples was
investigated in this study. Estimating the proportion of resistant
isolates within a herd based on pooled faecal samples is convenient
and least expensive to perform compared to individual samples.
This study showed that the use of pooled samples is justified as the
odds of finding resistant isolates within pooled samples did not
significantly differ compared to individual samples. This is in
accordance with studies among finisher pigs and feedlot cattle
[18], [31], although Wagner et al. [31] only found similar
resistance patterns for individual and pooled samples when
prevalence of resistance to an antimicrobial was .2%. Whereas
the study of Dunlop et al. [18] was based on a replica plating test
method, Wagner et al. [31] used broth microdilution, but could
not detect any resistant isolate within pooled samples of 10 samples
for antimicrobials with a low prevalence. In this study the
prevalence of isolates resistant to cefotaxime was also low and
resistant isolates were not detected among individual or pooled
samples when tested by broth microdilution. Surprisingly, isolates
resistant to cefotaxime in individual and pooled samples were
detected by replica plating even though the breakpoint concen-
tration was one-step higher in dilution compared to broth
microdilution. The fact that resistant isolates were found by
replica plating is probably due to the higher number of isolates
tested within each sample which increased the chance of picking at
least one resistant isolate. This result emphasizes the advantage of
testing multiple isolates per faecal sample for the determination of
resistance, especially when resistance is rare.
Simulation studies are used to investigate the impact of number
of isolates and number of samples tested per herd on the precision
of the estimated prevalence of resistance. These studies are usually
based on prevalence of resistance obtained from one herd or flock
of one farm only [17], [18], [19]. Since resistance patterns can be
clustered within a specific herd, variation between different herds
Table 3. Proportions and numbers of E. coli isolates tested resistant by replica plating and broth microdilution in individual and
pooled samples.
Individual samples Pooled samples
RP BMD RP BMD
Antimicrobial (n = 4320) (n = 500) (n = 450) (n = 50)
Amoxicillin 0.61 (n = 2652) 0.57 (n = 287) 0.50 (n = 225) 0.54 (n = 27)
Cefotaxime 0.02 (n = 83) 0 (n = 0) 0.004 (n = 2) 0 (n = 0)
Ciprofloxacin 0.11 (n = 475) 0.23 (n = 114) 0.06 (n = 28) 0.14 (n = 7)
Tetracycline 0.92 (n = 3963) 0.91 (n = 453) 0.95 (n = 427) 0.92 (n = 46)
Trimethoprim - sulfamethoxazole 0.47 (n = 2015) 0.44 (n = 220) 0.40 (n = 182) 0.44 (n = 22)
RP= Replica plating test method. BMD=Broth microdilution test method.
doi:10.1371/journal.pone.0044831.t003
Table 4. MIC distribution of 500 E. coli isolates (in %) tested for their antimicrobial susceptibility to ampicillin, tetracycline,
cefotaxime, ciprofloxacin, trimethoprim and sulphamethoxazole by broth microdilution.
E. coli MIC distribution mg/L (%)
N= 500 0 0.015 0.03 0.06 0.125 0.25 0.5 1 2 4 8 16 32 64 128 256 512 1024 2048
Ampicillin 0 0.2 8.2 30.6 3.6 0 0 57.4
Tetracycline 0.2 3.6 5.2 0.4 0 0.2 10.4 80
Cefotaxime 58.8 37.8 3.4 0 0
Ciprofloxacin 0.4 34 42.8 7.8 4.2 9 0.8 0 0 0 0.4 0.6
Trimethoprim 50.6 2.6 0.2 0 0 0 1.4 45.2
Sulfamethoxazole 45.4 1 0 0 0.2 0 0 0.8 52.6
doi:10.1371/journal.pone.0044831.t004
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can be large [32]. Therefore, this study was based on the resistance
results from five different farms to take possible farm influences
into account.
Composition of variance showed that variation among farms
accounted for 22% of the total variance in resistance, variation
among samples for 25% and variation among pens for 1%. Based
on these variances eight sampling strategies were simulated to
investigate the influence of several compositions of a pooled
sample on the precision of the estimated prevalence of resistance
on herd-level. All strategies provided comparable estimates of the
mean prevalence of resistance within each antimicrobial. Small
improvements in the precision of the estimated mean were
obtained by testing a larger total number of isolates and testing
more faecal samples relative to the number of isolates within a
faecal sample. It is not surprising that testing more isolates per
sample will result in a more precise estimate of the mean. More
interesting is the fact that the precision interval is more influenced
by the number of faecal samples included in a pooled sample. An
Table 5. Proportion E. coli isolates resistant to amoxicillin (25 mg/L), tetracycline (25 mg/L), ciprofloxacin (0.125 mg/L) and
trimethoprim/sulfamethoxazole (8/152 mg/L) obtained with 8 different sampling strategies.
Precision
# Isolates Total number 2.5th–97.5th
Strategy # Samples per sample of isolates Mean S.D. Percentiles
Proportion of E. coli resistant to 25 mg/L amoxicillin
1 4 5 20 0.61 0.06 0.50–0.73
2 5 4 20 0.61 0.06 0.51–0.72
3 10 2 20 0.61 0.05 0.52–0.70
4 10 4 40 0.61 0.04 0.54–0.69
5 20 2 40 0.61 0.03 0.55–0.68
6 5 20 100 0.61 0.04 0.53–0.70
7 10 10 100 0.61 0.03 0.55–0.68
8 20 5 100 0.61 0.03 0.56–0.66
Proportion of E. coli resistant to 25 mg/L tetracycline
1 4 5 20 0.92 0.04 0.82–0.98
2 5 4 20 0.92 0.04 0.83–0.98
3 10 2 20 0.92 0.03 0.85–0.98
4 10 4 40 0.92 0.03 0.86–0.96
5 20 2 40 0.92 0.02 0.87–0.96
6 5 20 100 0.92 0.03 0.85–0.97
7 10 10 100 0.92 0.02 0.87–0.96
8 20 5 100 0.92 0.03 0.85–0.97
Proportion of E. coli resistant to 0.125 mg/L ciprofloxacin
1 4 5 20 0.11 0.05 0.03–0.21
2 5 4 20 0.11 0.04 0.03–0.20
3 10 2 20 0.11 0.03 0.05–0.18
4 10 4 40 0.11 0.03 0.05–0.17
5 20 2 40 0.11 0.02 0.06–0.16
6 5 20 100 0.11 0.04 0.04–0.19
7 10 10 100 0.11 0.03 0.06–0.17
8 20 5 100 0.11 0.02 0.07–0.15
Proportion of E. coli resistant to 8/152 mg/L trimethoprim/sulfamethoxazole
1 4 5 20 0.46 0.06 0.36–0.58
2 5 4 20 0.47 0.05 0.36–0.58
3 10 2 20 0.47 0.05 0.38–0.55
4 10 4 40 0.47 0.04 0.40–0.54
5 20 2 40 0.46 0.03 0.40–0.53
6 5 20 100 0.46 0.04 0.39–0.55
7 10 10 100 0.47 0.03 0.40–0.53
8 20 5 100 0.47 0.03 0.42–0.52
using bootstrap resampling.
doi:10.1371/journal.pone.0044831.t005
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explanation for this is the fact that the largest proportion of total
variation was found between samples. This is in accordance to a
study of Dunlop among finisher pigs where 97,5% of the total
variance was attributable to variance between individual pigs [18].
The aim of this study was to determine one optimal sampling
strategy to estimate the prevalence of resistance to amoxicillin,
tetracycline, cefotaxime, ciprofloxacin and tmp/s within veal calf
herds. In our study, the optimal sampling strategy from the
perspective of precision of the estimated levels of resistance and
practicality, consists of a pooled faecal sample from 20 individual
animals, from which 90 isolates are tested for their susceptibility by
replica plating.
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